The Haploinsufficient Col3a1 Mouse as a Model for Vascular Ehlers-Danlos Syndrome

被引:33
|
作者
Cooper, T. K. [1 ]
Zhong, Q. [1 ]
Krawczyk, M. [2 ]
Tae, H-J. [2 ]
Mueller, G. A. [2 ]
Schubert, R. [3 ]
Myers, L. A. [4 ]
Dietz, H. C. [4 ]
Talan, M. I. [2 ]
Briest, W. [2 ]
机构
[1] Penn State Coll Med, Dept Comparat Med, Milton S Hershey Med Ctr, Hershey, PA USA
[2] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA
[3] Univ Heidelberg, Med Fac Mannheim, D-6900 Heidelberg, Germany
[4] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
Col3a1; mouse model; vascular Ehlers-Danlos; haploinsufficient; SYNDROME TYPE-IV; AORTIC-ANEURYSM; GENETIC FEATURES; MARFAN-SYNDROME; III COLLAGEN; MICE; PATHOGENESIS; WALL; THROMBOSIS; MUTATIONS;
D O I
10.1177/0300985810374842
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Vascular Ehlers-Danlos syndrome is a rare genetic disorder resulting from mutations in the alpha-1 chain of type III collagen (COL3A1) and manifesting as tissue fragility with spontaneous rupture of the bowel, gravid uterus, or large or medium arteries. The heterozygous Col3a1 knockout mouse was investigated as a model for this disease. The collagen content in the abdominal aorta of heterozygotes was reduced, and functional testing revealed diminishing wall strength of the aorta in these mice. Colons were grossly and histologically normal, but reduced strength and increased compliance of the wall were found in heterozygotes via pressure testing. Although mice demonstrated no life-threatening clinical signs or gross lesions of vascular subtype Ehlers-Danlos syndrome type IV, thorough histological examination of the aorta of heterozygous mice revealed the presence of a spectrum of lesions similar to those observed in human patients. Lesions increased in number and severity with age (0/5 [0%] in 2-month-old males vs 9/9 [100%] in 14-month-old males, P < .05) and were more common in male than female mice (23/26 [88.5%] vs 14/30 [46.7%] in 9- to 21-month-old animals, P < .05). Haploinsufficiency for Col3al in mice recapitulates features of vascular Ehlers-Danlos syndrome in humans and can be used as an experimental model.
引用
收藏
页码:1028 / 1039
页数:12
相关论文
共 50 条
  • [21] Ehlers-Danlos Syndrome Type IV, Vascular Type, Which Demonstrated a Novel Point Mutation in the COL3A1 Gene
    Sadakata, Rinako
    Hatamochi, Atsushi
    Kodama, Keiji
    Kaga, Akiko
    Yamaguchi, Takefumi
    Soma, Tomoyuki
    Usui, Yutaka
    Nagata, Makoto
    Ohtake, Akira
    Hagiwara, Koichi
    Kanazawa, Minoru
    INTERNAL MEDICINE, 2010, 49 (16) : 1797 - 1800
  • [22] A novel heterozygous variant in COL3A1 related to vascular ehlers-danlos syndrome found in study of bleeding of unknown cause
    Garcia Jaen, P.
    Navarro Garcia, J. M.
    Palomino Mendoza, D.
    Bandini, P.
    Costas Rodriguez, T.
    Cabrero Segurado, M. D. L. A.
    Gonzalez Porras, R.
    Corrales Insa, I.
    Bastida Bermejo, J. M.
    HAEMOPHILIA, 2024, 30 : 155 - 156
  • [23] Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family
    Jorgensen, Agnete
    Fagerheim, Toril
    Rand-Hendriksen, Svend
    Lunde, Per I.
    Vorren, Torgrim O.
    Pepin, Melanie G.
    Leistritz, Dru F.
    Byers, Peter H.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2015, 23 (06) : 796 - 802
  • [24] Case report: A novel COL3A1 variant in a Colombian patient with isolated cerebrovascular involvement in vascular Ehlers-Danlos syndrome
    Valencia-Cifuentes, Valeria
    Sinisterra-Diaz, Stiven Ernesto
    Quintana-Pena, Valentina
    Folleco, Edgar
    Nastasi-Catanese, Jose A.
    Pachajoa, Harry
    Fernandez-Cubillos, Juan P.
    FRONTIERS IN MEDICINE, 2024, 11
  • [25] Vascular Ehlers-Danlos syndrome, an often unrecognized clinical entity: a case report of a novel mutation in the COL3A1 gene
    Frkovic, Sanda Huljev
    Sliskovic, Ana Marija
    Toivonen, Mia
    Gregorek, Andrea Crkvenac
    Sutalo, Ana
    Kirhmajer, Majda Vrkic
    CROATIAN MEDICAL JOURNAL, 2022, 63 (04) : 394 - 398
  • [26] Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection
    Gu, Guangchao
    Yang, Hang
    Cui, Lijia
    Fu, Yuanyuan
    Li, Fangda
    Zhou, Zhou
    Zheng, Yuehong
    VASCULAR AND ENDOVASCULAR SURGERY, 2018, 52 (02) : 138 - 142
  • [27] Loss of Col3a1, the Gene for Ehlers-Danlos Syndrome Type IV, Results in Neocortical Dyslamination
    Jeong, Sung-Jin
    Li, Shihong
    Luo, Rong
    Strokes, Natalie
    Piao, Xianhua
    PLOS ONE, 2012, 7 (01):
  • [28] Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?
    Utama, Sasiwimon
    Cale, Jessica M.
    Mitrpant, Chalermchai
    Fletcher, Sue
    Wilton, Steve D.
    Aung-Htut, May T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [29] COL3A1 Gene Mutation Predicts Arterial Involvement and Prognosis in Vascular Ehlers Danlos Syndrome
    Shalhub, Sherene
    McDonnel, Nazli
    Cecchi, Alana C.
    Azizzadeh, Ali
    Charlton-Ouw, Kristofer M.
    Black, James
    Pyeritz, Reed
    Estrera, Anthony L.
    Safi, Hazim
    Milewicz, Dianna
    JOURNAL OF VASCULAR SURGERY, 2013, 57 (05) : 25S - 26S
  • [30] Acrogeric phenotype in Ehlers-Danlos syndrome type IV attributed to a missense mutation in the COL3A1 gene
    Jansen, T
    De Paepe, A
    Nuytinck, L
    Altmeyer, P
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (05) : 1086 - 1087